Search results
Results from the WOW.Com Content Network
(The Center Square) – The Michigan Department of Health and Human Services reported opioid overdose deaths in the state decreased by 5.7% in the first nine months of 2023, with 2,826 deaths ...
Treatment Improvement Protocols (TIPs) are a series of best-practice manuals for the treatment of substance use and other related disorders. The TIP series is published by the Substance Abuse and Mental Health Services Administration (SAMHSA), an operational division of the U.S. Department of Health and Human Services.
Opioid agonist therapy. Opioid agonist therapy (OAT) is a treatment in which prescribed opioid agonists are given to patients who live with Opioid use disorder (OUD). [1] In the case of methadone maintenance treatment (MMT), methadone is used to treat dependence on heroin or other opioids, and is administered on an ongoing basis. [2]
An opioid overdose is toxicity due to excessive consumption of opioids, such as morphine, codeine, heroin, fentanyl, tramadol, and methadone. [3][5] This preventable pathology can be fatal if it leads to respiratory depression, a lethal condition that can cause hypoxia from slow and shallow breathing. [3] Other symptoms include small pupils ...
The Centers for Disease Control and Prevention (CDC) on Thursday issued new guidance for providers on prescribing opioids for chronic pain, updating previous recommendations that had been in place ...
The Centers for Disease Control and Prevention (CDC) on Thursday released draft updated guidelines for prescribing opioids that would give doctors more flexibility as the medical community seeks ...
Opioid use disorder (OUD) is a substance use disorder characterized by cravings for opioids, continued use despite physical and/or psychological deterioration, increased tolerance with use, and withdrawal symptoms after discontinuing opioids. [ 12 ] Opioid withdrawal symptoms include nausea, muscle aches, diarrhea, trouble sleeping, agitation ...
The city of Baltimore won $266 million in its lawsuit accusing top drug distributors McKesson and Cencora of fueling an epidemic of opioid addiction in the U.S., and is expected to seek billions ...